Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. 1994

S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
Department of Pharmacology, University of Toronto, Ontario, Canada.

We present a comprehensive comparison of the anatomical distributions of the cloned mu, delta and kappa opioid receptor mRNA in rat brain. Northern blot analysis revealed that mRNA species encoding the three receptors differed in size and were differentially localized in brain regions. In peripheral tissues analyzed, the 3 mRNA species were detected only in the spinal cord. The distributions of mu, delta and kappa receptor mRNA in rat brain were examined by in situ hybridization histochemistry using gene-specific probes. Mu receptor mRNA was predominately localized to thalamic, brainstem and reticular core nuclei and was highest in the habenular and thalamic nuclei. In contrast, kappa receptor mRNA was expressed in hippocampus including dentate gyrus, hypothalamic and some thalamic nuclei and also present in cortex, caudate putamen, olfactory tubercle and nucleus accumbens. Delta receptor mRNA was prominent in cerebral cortex, olfactory tubercle, hippocampus, caudate putamen and nucleus accumbens. These results show that the mRNA distribution for each opioid receptor subtype in brain is unique and correlate well with the known distribution of the corresponding opioid receptor binding sites.

UI MeSH Term Description Entries
D008297 Male Males
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001345 Autoradiography The making of a radiograph of an object or tissue by recording on a photographic plate the radiation emitted by radioactive material within the object. (Dorland, 27th ed) Radioautography
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013462 Sulfur Radioisotopes Unstable isotopes of sulfur that decay or disintegrate spontaneously emitting radiation. S 29-31, 35, 37, and 38 are radioactive sulfur isotopes. Radioisotopes, Sulfur
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats

Related Publications

S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
December 1995, Brain research. Molecular brain research,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
December 1986, Brain research,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
October 1986, Pharmacological research communications,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
December 1994, The Journal of comparative neurology,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
February 1987, Brain research,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
June 2003, Life sciences,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
January 1987, Brain research,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
July 2000, Brain research bulletin,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
May 1995, Neuroscience letters,
S R George, and R L Zastawny, and R Briones-Urbina, and R Cheng, and T Nguyen, and M Heiber, and A Kouvelas, and A S Chan, and B F O'Dowd
November 1990, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!